World Drug Safety Congress Europe 2019 - 10 and 11 September - Amsterdam
Explore the use of big data and AI in pharmacovigilance, examine benefit-risk management strategies and patient-centric approaches; discuss how you can tackle the challenges of social media and drug safety legislation globally. Make sure you are at the heart of the new drug safety era and participate in these critical discussions.
WORLD DRUG SAFETY FOCUSES ON:
How to plan for the wider international drug safety landscape
How to work compliantly with a global regulatory overview and recent developments
How to establish a robust approach to safety in oncology and advanced therapies
How to harness Big Data and emerging technologies such as AI to support your safety measures
How to manage drug safety operations in light of increasing complexities
How to manage data and electronic submissions better
How to effectively process the volume of cases
How to operate within financial and logistical constraints
All companies in the pharma industry have an enormous opportunity to better their drug safety capabilities, technological functions and risk management measures. It is core to ensuring regulatory compliance and establishing a robust PV strategy. It is core to your professional future.